Merck Settles Class Suit Targeting Coppertone Claims, Denies Wrongdoing
This article was originally published in The Tan Sheet
Executive Summary
Merck agrees to pay a maximum of $10 million to consumers to settle class-action case and to comply with labeling and claims regulations that will become law in December for most firms under an FDA final rule. The settlement in federal court resolves separate litigation against Coppertone filed in California state court.